Sildenafil citrate on nitrergic transmission in anococcygeus muscles from the urogenital system of male and female mice

European Journal of Pharmacology

Volumn 400, Issue 2-3, 2000, Pages 305-312

  Frith, Dan ^a   Gibson, Alan ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anococcygeus; Forskolin; mouse; Nitrergic; Nitric oxide (NO); Papaverine; Sildenafil; Sodium nitroprusside

Indexed keywords

CARBACHOL; FORSKOLIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PAPAVERINE; SILDENAFIL;

ANIMAL TISSUE; ANOCOCCYGEUS MUSCLE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; IN VITRO STUDY; MALE; MOUSE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; CARBACHOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORSKOLIN; MALE; MICE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PAPAVERINE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SEX FACTORS; SUBSTRATE SPECIFICITY; SYNAPTIC TRANSMISSION; UROGENITAL SYSTEM;

EID: 0034698347     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00406-4     Document Type: Article

References (27)

1. Ballard S.A., Gingell C.J., Tang K., Turner L.A., Price M.E., Naylor A.M. Effects of sildenafil on the relaxations of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isoenzymes. J. Urol. 159:1998;2164-2171.
2. Beavo J.A., Reifsnyder D.H. Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11:1990;150-155.
3. Burnett A.L., Calvin D.C., Silver R.I., Peppas D.S., Docimo S.G. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J. Urol. 158:1997;75-78.
4. Carter A.J., Ballard S.A., Naylor A.M. Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile function in the anesthetised dog. J. Urol. 160:1998;242-246.
5. Cellek S., Moncada S. Nitrergic neurotransmission mediates the non-adrenergic non-cholinergic responses in clitoral corpus cavernosum of the rabbit. Br. J. Pharmacol. 125:1998;1627-1629.
6. Chuang A.T., Strauss J.D., Murphy R.A., Steers W.D. Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J. Urol. 160:1998;257-261.
7. Fukazawa Y., Iguchi T., Bern H.A. Mouse anococcygeus muscle: sexual dimorphism and responsiveness to sex hormones. J. Endocrinol. 152:1997;229-237.
8. Gibson A., Gillespie J.S. The effect of immunosympathectomy and of 6-hydroxydopamine on the responses of the rat anococcygeus to nerve stimulation and to some drugs. Br. J. Pharmacol. 47:1973;261-267.
9. G-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br. J. Pharmacol. 99:1990;602-606.
10. G-monomethyl L-arginine on the responses of the rat anococcygeus muscle to NANC nerve stimulation. Br. J. Pharmacol. 98:1989;1080-1082.
11. Huddart H., Langton P., Saad K.H.M. Inhibition by papaverine of calcium movements and tension in the smooth muscle of rat vas deferens and urinary bladder. J. Physiol. 349:1984;189-194.
12. Jeremy J.Y., Ballard S.A., Naylor A.M., Miller M.A.W., Angelini G.D. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br. J. Urol. 79:1997;958-963.
13. Kaplan S.A., Reis R.B., Kohn I.J., Ikeguchi E.F., Laor E., Te A.E., Martins A.C.P. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology. 53:1999;481-486.
14. Langtry H.D., Markham A. Sildenafil - a review of its use in erectile dysfunction. Drugs. 57:1999;967-989.
15. Li C.G., Rand M.J. Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clin. Exp. Pharmacol. Physiol. 16:1989;933-938.
16. Marshall S.M. Sildenafil: a revolutionary therapy? Diabetic Med. 15:1998;897-899.
17. Miller M.A.W., Morgan R.J., Thompson C.S., Mikhailidis D.P., Jeremy J.Y. Adenylate and guanylate cyclase activity in the penis and aorta of the diabetic rat: an in vitro study. Br. J. Urol. 74:1994;106-111.
18. Mirzazadeh S., Hobbs A.J., Tucker J.F., Gibson A. Cyclic nucleotide content of the rat anococcygeus muscle during relaxations induced by drugs or by non-adrenergic, non-cholinergic field stimulation. J. Pharm. Pharmacol. 43:1991;247-257.
19. Moreland R.B., Goldstein I., Traish A. Sildenafil, a novel inhibitor of phosphodiesterase type V in human corpus cavernosum smooth muscle cells. Life Sci. 62:1998;PL309-PL318.
20. Moreland R.B., Goldstein I., Kim N.N., Traish A. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: research and clinical implications in erectile dysfunction. Trends. Endocrinol. Metab. 10:1999;97-104.
21. Naylor A.M. Endogenous neurotransmitters mediating penile erection. Br. J. Urol. 81:1998;424-431.
22. Numberg H.G., Hensley P.L., Lauriello J., Parker L.M., Keith S.J. Sildenafil for women patients with antidepressant-induced sexual dysfunction. Psychiatr. Serv. 50:1999;1076-1078.
23. O'Kane K., Gibson A. Characterisation of nitrergic transmission in the isolated anococcygeus muscle of the female mouse. Eur. J. Pharmacol. 377:1999;69-74.
24. Park K., Moreland R.B., Goldstein I., Atala A., Traish A. Sildenafil inhibits phosphodiesterase 5 in human clitoral corpus cavernosum smooth muscle. Biochem. Biophys. Res. Commun. 249:1998;612-617.
25. 2+ levels and relaxation in the rat anococcygeus muscle. Eur. J. Pharmacol. 174:1989;297-299.
26. Shen W.W., Urosevich Z., Clayton D.O. Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J. Reprod. Med. 44:1999;535-542.
27. Stief C.G., Uckert S., Becker A.J., Truss M.C., Jonas U. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J. Urol. 159:1998;1390-1393.